Related Experiment Video
Updated: Jul 3, 2026
07:35
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
Published on: April 25, 2014
Multidrug resistance in Mycobacterium tuberculosis
1Hôpital Ambroise Paré, 9, Avenue Charles de Gaulle, 92 104 Boulogne Cedex, France.
International Journal of Antimicrobial Agents
|February 1, 1997
Summary
Mycobacterium tuberculosis primarily develops drug resistance through target alteration via mutations, affecting key tuberculosis drugs. Other resistance mechanisms like target overproduction and altered permeability are also observed.
Area of Science:
- Microbiology
- Molecular Biology
- Pharmacology
Background:
- Antimicrobial resistance in Mycobacterium tuberculosis poses a significant global health challenge.
- Understanding resistance mechanisms is crucial for effective tuberculosis treatment.
Purpose of the Study:
- To investigate the mechanisms of resistance employed by Mycobacterium tuberculosis against short-course chemotherapy drugs.
- To identify the predominant resistance pathways utilized by the bacterium.
Main Methods:
- Analysis of known antimicrobial resistance mechanisms.
- Review of genetic mutations and cellular processes in resistant M. tuberculosis strains.
Main Results:
- Target alteration through mutations is the most common resistance mechanism for isoniazid, pyrazinamide, ethionamide, rifampicin, streptomycin, and fluoroquinolones.
- Drug inactivation has not been identified as a resistance mechanism.
- Target overproduction contributes to resistance against isoniazid and ethionamide.
- Altered permeability and efflux systems play a role in streptomycin and fluoroquinolone resistance.
Conclusions:
- Mycobacterium tuberculosis utilizes diverse resistance strategies, predominantly target modification.
- The absence of drug-inactivating enzymes highlights the importance of understanding mutational and cellular resistance pathways.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:31Defense Against Bacterial Pathogens
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...